Applied DNA Sciences, Inc. (APDN) Financials
APDN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 9.9 million | 5.8 million |
2023-09-30 | 13.7 million | 8.8 million |
2023-06-30 | 15.8 million | 8.6 million |
2023-03-31 | 19.2 million | 9.2 million |
APDN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -3.8 million | 340705 |
2023-09-30 | -2.6 million | 341495 |
2023-06-30 | -1.5 million | 340042 |
2023-03-31 | 160049 | 258604 |
APDN Net Income
No data available :(
APDN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 3.4 million | - | 1.1 million |
2023-09-30 | 7.2 million | - | 1.2 million |
2023-06-30 | 10.8 million | - | 1.4 million |
2023-03-31 | 12.3 million | - | 1.5 million |
APDN Shares Outstanding
APDN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 935815 | 3.1 million | - |
2023-09-30 | 117072 | 938907 | 3.3 million | - |
2023-06-30 | 161800 | 836123 | 3.3 million | - |
2023-03-31 | 54339 | 988744 | 3.5 million | - |
APDN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 891164 | 660067 |
2023-09-30 | 779736 | 700740 |
2023-06-30 | 2.9 million | 1.6 million |
2023-03-31 | 4.4 million | 2.6 million |
APDN
Price: $4.37
52 week price:
Earnings Per Share: -0.55 USD
P/E Ratio: -1.10
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 276529
Ebitda: -5.5 millionMarket Capitalization: 6.4 million